16-81012064-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001100624.3(CENPN):c.125G>A(p.Arg42Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000194 in 1,614,110 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001100624.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CENPN | NM_001100624.3 | c.125G>A | p.Arg42Gln | missense_variant | 2/11 | ENST00000305850.10 | NP_001094094.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CENPN | ENST00000305850.10 | c.125G>A | p.Arg42Gln | missense_variant | 2/11 | 1 | NM_001100624.3 | ENSP00000305608 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152144Hom.: 1 Cov.: 33
GnomAD3 exomes AF: 0.000278 AC: 70AN: 251398Hom.: 0 AF XY: 0.000265 AC XY: 36AN XY: 135900
GnomAD4 exome AF: 0.000187 AC: 274AN: 1461846Hom.: 1 Cov.: 31 AF XY: 0.000188 AC XY: 137AN XY: 727226
GnomAD4 genome AF: 0.000256 AC: 39AN: 152264Hom.: 1 Cov.: 33 AF XY: 0.000269 AC XY: 20AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2021 | The c.125G>A (p.R42Q) alteration is located in exon 2 (coding exon 1) of the CENPN gene. This alteration results from a G to A substitution at nucleotide position 125, causing the arginine (R) at amino acid position 42 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at